Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers. [PDF]
Bondì G +7 more
europepmc +1 more source
The Role of Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma: State of the Art. [PDF]
Andolfi M, Salati M, Refai M.
europepmc +1 more source
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma. [PDF]
Li YR +13 more
europepmc +1 more source
The Role of Dosimetric Parameters in Radiation Pneumonitis: A Functional Approach in Adjuvant Treatment of Malignant Pleural Mesothelioma. [PDF]
Dominici L +10 more
europepmc +1 more source
Protein phosphatase 2 phosphatase activator (PTPA) promotes oncogene-induced senescence and carboplatin response in human malignant pleural mesothelioma cells. [PDF]
Nigliato E +14 more
europepmc +1 more source
Recovery from fulminant immune-related myocarditis induced by ipilimumab plus nivolumab in malignant pleural mesothelioma: a case report. [PDF]
Konya Y +8 more
europepmc +1 more source
Effectiveness of Surgical Treatment on Survival of Patients with Malignant Pleural Mesothelioma. [PDF]
Báez-Saldaña R +4 more
europepmc +1 more source
Jejunal Metastasis from Malignant Pleural Mesothelioma during Long-Term Nivolumab Therapy: A Case Report and Literature Review. [PDF]
Minagi H +7 more
europepmc +1 more source
Pseudoachalasia Due to Malignant Pleural Mesothelioma Involving the Esophagus. [PDF]
Honda M +4 more
europepmc +1 more source

